Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00689117 · ClinicalTrials.gov registry record · Phase 3
A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel
A Phase 3 study, sponsored by Stiefel, a GSK Company.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,649
- Enrollment target
NCT00689117: Completed Phase 3 study, sponsored by Stiefel, a GSK Company.
NCT00689117 is a Phase 3 study that has completed, run by Stiefel, a GSK Company. The registered enrollment target is 1,649 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (114% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00689117, a Phase 3 study, has completed, sponsored by Stiefel, a GSK Company.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,649 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate the safety and effectiveness of CT Gel in subjects with acne vulgaris. The hypothesis is that CT Gel is superior to Clindamycin Gel, Tretinoin Gel and Vehicle Gel for the treatment of acne vulgaris.
Primary Outcome
Acne lesion counts (inflammatory \[papules, pustules, nodules\], non-inflammatory \[open and closed comedones\], and total) were performed on the face of participants. Change from baseline is defined as Week 12 values minus Baseline values. The total lesion count is the sum of the inflammatory and non-inflammatory lesion counts.
Interventions
- DRUG Vehicle Gel
- DRUG CT Gel
- DRUG Clindamycin Gel (clindamycin )
- DRUG Tretinoin Gel (tretinoin)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,649 participants |
| Start Date | 2008-04 |
| Est. Completion | 2009-05 |
| Phase | Phase 3 |
What the finished NCT00689117 record still lists
NCT00689117 is an interventional study that assigns participants to a tested intervention. Its 1,649 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (114% higher).
The record links to 0 conditions, and to 4 interventions - of which Vehicle Gel is the first listed.
NCT00689117 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00689117 about?
NCT00689117 is a clinical study titled "A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel". The purpose of this study is to demonstrate the safety and effectiveness of CT Gel in subjects with acne vulgaris. The hypothesis is that CT Gel is superior to Clindamycin Gel, Tretinoin Gel and Vehicle Gel for the treatment of acne vulgaris.
What is the current status of trial NCT00689117?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,649 participants. The study started on 2008-04. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00689117?
The interventions under investigation include: Vehicle Gel (DRUG), CT Gel (DRUG), Clindamycin Gel (clindamycin ) (DRUG), Tretinoin Gel (tretinoin) (DRUG).
Who is sponsoring clinical trial NCT00689117?
This trial is sponsored by Stiefel, a GSK Company, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00689117's enrollment target sits among peer trials
1,649 140th of 2000 higher than 1,861 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04510129 · 1,650 participants
A Multicenter Cancer Biospecimen Collection Study
- NCT05612750 · 1,650 participants · NA
Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
- NCT06215716 · 1,650 participants · Phase 3
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
- NCT07046260 · 1,650 participants
Prospective Study to Assess a Diagnostic Aid for Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia